First approved therapy to address hyperphagia in individuals with Prader-Willi syndrome Management to host conference call and webcast today, March 26th, at 5:30pm ET REDWOOD CITY, Calif., March 26, ...

First approved therapy to address hyperphagia in individuals with Prader-Willi syndrome Management to host conference call ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

A new study in the journal Diabetes Technology & Therapeutics evaluated the effects of a regimen of inhaled technosphere ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

The mean percentage of time that patients were ... All other multiplicity-controlled CGM outcomes reflective of hyperglycemia that were measured were significantly better in the AID group than ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

"In Type 1 and Type 2 diabetes, RT-CGM lowered HbA1c, improved time spent within the target glucose range (70–180 mg/dL), and reduced episodes of hypoglycemia in T1D and hypergl ...

Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of ...

More serious meds can mean more serious consequences if they ... Once expired, it may not work effectively and can cause hyperglycemia, which can lead to some very serious complications ...